Literature DB >> 17288881

Occult primary head and neck carcinoma.

Cecelia E Schmalbach1, Frank R Miller.   

Abstract

Unknown primary carcinoma presenting as cervical lymph node metastasis accounts for approximately 5% of all head and neck malignancies. The typical presentation involves a middle-aged man with a painless neck mass that has been present for several months. Over 90% of these malignancies represent squamous cell carcinoma originating within Waldeyer's ring (lymphoid tissue of the nasopharynx, tonsil, and base of tongue). The remainder are comprised of adenocarcinoma, melanoma, and other rare histologic variants. The ability to identify the occult primary tumor is imperative because identification allows site-specific therapy and avoidance of wide-field radiation side effects. Following confirmation of metastatic cervical disease with fine-needle aspiration, all patients presenting with an unknown primary carcinoma require a thorough head and neck history and physical examination, radiographic imaging, panendoscopy with directed biopsies of Waldeyer's ring, and bilateral tonsillectomy. Positron emission tomography has proved helpful in identifying occult primary tumors of the head and neck region.

Entities:  

Mesh:

Year:  2007        PMID: 17288881     DOI: 10.1007/s11912-007-0012-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  26 in total

1.  Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.

Authors:  C Nanni; D Rubello; P Castellucci; M Farsad; R Franchi; S Toso; C Barile; L Rampin; O Nibale; S Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02-22       Impact factor: 9.236

2.  Metastatic adenocarcinoma of the colon presenting as a mass in the mandible.

Authors:  A Corde Mason; Kodi K Azari; Linda M Farkas; Umamaheswar Duvvuri; Eugene N Myers
Journal:  Head Neck       Date:  2005-08       Impact factor: 3.147

3.  Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.

Authors:  Jeffrey D Wagner; Donald Schauwecker; Darrell Davidson; Theodore Logan; John J Coleman; Gary Hutchins; Charlene Love; Stacie Wenck; Joanne Daggy
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

4.  Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.

Authors:  Mark K Wax; Larry L Myers; Edward C Gabalski; Syed Husain; Jayakumari M Gona; Hani Nabi
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-06

Review 5.  Cystic metastasis versus branchial cleft carcinoma: a diagnostic challenge.

Authors:  Russell D Briggs; Anna M Pou; Vicki J Schnadig
Journal:  Laryngoscope       Date:  2002-06       Impact factor: 3.325

6.  Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure.

Authors:  P J Colletier; A S Garden; W H Morrison; H Goepfert; F Geara; K K Ang
Journal:  Head Neck       Date:  1998-12       Impact factor: 3.147

Review 7.  PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.

Authors:  Lale Kostakoglu; Stanley J Goldsmith
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

8.  Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma.

Authors:  C Maulard; M Housset; P Brunel; J Huart; L Ucla; C Rozec; S Delanian; F Baillet
Journal:  Laryngoscope       Date:  1992-08       Impact factor: 3.325

Review 9.  Diagnostic and therapeutic management of cancer of an unknown primary.

Authors:  N Pavlidis; E Briasoulis; J Hainsworth; F A Greco
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

10.  FDG-PET. A possible prognostic factor in head and neck cancer.

Authors:  W Halfpenny; S F Hain; L Biassoni; M N Maisey; J A Sherman; M McGurk
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

View more
  11 in total

Review 1.  Radiographic imaging of human papillomavirus related carcinomas of the oropharynx.

Authors:  Amanda S Corey; Patricia A Hudgins
Journal:  Head Neck Pathol       Date:  2012-07-03

2.  Squamous cell carcinoma of the tonsillar remnant--clinical presentation and oncological outcome.

Authors:  Christopher J Skilbeck; Jean-Pierre Jeannon; Mary O'Connell; Peter R Morgan; Ricard Simo
Journal:  Head Neck Oncol       Date:  2011-01-19

3.  Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival.

Authors:  Miloslav Pala; Pavla Novakova; Zdena Pechacova; Lucie Vesela; Antonin Vrana; Jarmila Sukova; Petra Holeckova; Tereza Drbohlavova; Tomas Podlesak; Lubos Petruzelka
Journal:  Strahlenther Onkol       Date:  2022-08-09       Impact factor: 4.033

Review 4.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

Review 5.  Head and neck cancer.

Authors:  Athanassios Argiris; Michalis V Karamouzis; David Raben; Robert L Ferris
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

6.  Diagnosis and treatment of a neck node swelling suspicious for a malignancy: an algorithmic approach.

Authors:  A J M Balm; M L F van Velthuysen; F J P Hoebers; W V Vogel; M W M van den Brekel
Journal:  Int J Surg Oncol       Date:  2010-05-30

7.  Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.

Authors:  Jessica Clark; Caroline C Jeffery; Han Zhang; Tim Cooper; Daniel A O'Connell; Jeffrey Harris; Hadi Seikaly; Vincent L Biron
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-09-15

8.  Adequacy of fine-needle aspiration specimens for human papillomavirus infection molecular testing in head and neck squamous cell carcinoma.

Authors:  Ricardo R Lastra; Michelle R Pramick; Megan O Nakashima; Gregory S Weinstein; Kathleen T Montone; Virginia A Livolsi; Zubair W Baloch
Journal:  Cytojournal       Date:  2013-10-29       Impact factor: 2.091

9.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

10.  Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.

Authors:  Angelica M Lagunas; Jianchun Wu; David L Crowe
Journal:  Oncotarget       Date:  2017-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.